Nasal Swabs Could Help Identify Emerging Viruses, Yale Researchers Say
The researchers are looking for little known viruses in certain samples to try to identify new diseases before they become a threat. “COVID came as a surprise. All of the sudden, there was an outbreak, and people discovered that there was a new virus that could cause an illness,” Dr. Ellen Foxman, Yale School of Medicine immunologist, said. “What we want to do going forward is be able to get ahead of that.”Source: NBC News CT
A Status Report on AI in Laboratory Medicine
Artificial intelligence (AI) models in healthcare have the potential to improve the precision and speed of personalized medicine for patients, in some cases helping to identify the best treatment or preventive care. Clinicians are already implementing these models in areas such as early detection of sepsis and analyzing radiology images for diagnosis of prostate cancer and other conditions. It’s a growing area of interest that laboratory medicine professionals should pay attention to, as data generated by laboratory testing is a major component incorporated into AI tools to generate clinical decisions.Source: AACC Clinical Laboratory News
What’s the difference between RSV, the flu and covid-19?
Murray said his hospital is already starting to see RSV cases plateau. It’s hard to predict what might happen in the coming weeks, but it’s likely that flu cases will continue to rise. “If ever there was a year to get your flu vaccine, or to have your child get a flu vaccine, this is a year,” he said.Source: Washington Post
ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology
Madeline Mayday, BS, a fourth-year Experimental Pathology graduate student in the Laboratory of Diane Krause, MD, PhD, was recently awarded a 2022 National Institute of Diabetes and Digestive and Kidney Diseases Hematology Centers Program Type B Pilot and Feasibility grant
Yale Researchers Join NIH Bridge2AI Program
The use of AI to analyze complex datasets presents a groundbreaking opportunity to answer questions previously beyond the reach of biomedical researchers. The Bridge2AI program will support the creation of accessible, AI-ready datasets that can be used multiple times for a range of medical challenges.
What We Learned About COVID-19 and Cold and Flu Season
Day-to-day life changed a lot when COVID-19 hit. To curb the spread of the virus, health experts urged us to social distance, wear a mask, and wash our hands all the time. Then a surprising thing happened. “All the normal respiratory infections we usually get -- from cold and flu viruses -- didn’t happen, which was very dramatic,” says Ellen Foxman, MD, PhD. She’s an immunobiologist at Yale Medicine and an assistant professor of laboratory medicine and immunobiology at Yale School of Medicine.Source: WebMD
Yale-developed Vaccine Offers Superior Protection Against Omicron Variants
The experimental vaccines use engineered lipid nanoparticles to deliver mRNA to cells with “instructions” to create spike proteins from mutating variants, which the virus uses to attach to and infect cells.Source: YaleNews
Understanding Poor Vaccine Responses in Individuals With Weakened Immune Systems
Yale researchers have received a $12 million award from the NIH as part of the Human Immune Project Consortium to study vaccine responses in vulnerable groups, including patients with multiple sclerosis (MS) undergoing B cell depletion therapy, older adults including particularly vulnerable older residents of long-term care facilities, and certain individuals with sickle cell disease.
OpEd Project Elevates Voices of Women and Underrepresented Faculty at Yale
The goal of the Public Voices Fellowship, an opportunity for 20 faculty at Yale along with those from other universities to participate in the OpEd Project, is for women and underrepresented faculty to write op-eds that appear in leading publications, including the Los Angeles Times, the Boston Globe, Newsweek, and the Washington Post. But the year-long program does much more than simply expand the voices of those engaged in public debate. It has a lasting impact on the fellows and their careers, says Reina Maruyama, PhD, professor of physics and astronomy and Chair of Women Faculty Forum (WFF).
Yale Pathologists Participating in Annual USCAP Meeting to Share Research, Advancements
Pathologists and research scientists from Department of Pathology at Yale School of Medicine will be involved in more than 40 presentations and sessions at the United States and Canadian Academy of Pathology (USCAP) 2022 Annual Meeting in Los Angeles March 19-24.